Clinical Trial Update: Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection [Phase 4]

View source ↗

Summary

Phase 4 trial updating on vitamin D supplementation for prevention and mitigation of COVID-19 and related respiratory infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection
• Vitamin Deficiency

Drugs mentioned

• Vitamin D supplementation (Cholecalciferol)

Snippet

Sponsor: Medical University of South Carolina | Conditions: COVID-19, Vitamin D Deficiency | Phase 4 | Status: ACTIVE_NOT_RECRUITING